ARTICLE | Clinical News
Synflorix regulatory update
April 6, 2015 7:00 AM UTC
GlaxoSmithKline said Japan approved Synflorix to prevent invasive infectious diseases and pneumonia caused by pneumococcus in infants. Synflorix is being commercialized by Japan Vaccine Co. Ltd. (Toky...